Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,43
KB0,00
PKN68,9169,030,13
Msft435,33435,42-0,19
Nokia4,4274,4310,73
IBM248,9249,09-0,07
Mercedes-Benz Group AG54,2654,270,61
PFE23,4823,49-1,59
06.05.2025 16:55:57
Indexy online
AD Index online
select
AD Index online
 

  • 06.05.2025 16:54:08
Medicover-B Rg (Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
240,00 0,42 1,00 7 545 909
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.05.2025
Popis společnosti
Obecné informace
Název společnostiMedicover AB
TickerMCOV B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares Class C
RICMCOVb.ST
ISINSE0009778848
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 47 256
Akcie v oběhu k 31.12.2024 150 138 919
MěnaEUR
Kontaktní informace
UliceRiddargatan 12 A 3Tr
MěstoSTOCKHOLM
PSČ114 35
ZeměSweden
Kontatní osobaHanna Bjellquist
Funkce kontaktní osobyHead of Investor Relations
Telefon46 840 017 600
Kontatní telefon46 840 017 606

Business Summary: Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Medicover AB revenues increased 20% to EUR2.09B. Net income decreased 5% to EUR16.7M. Revenues reflect Healthcare Services segment increase of 22% to EUR1.46B, Diagnostic Services segment increase of 15% to EUR635M. Net income was offset by Labor & Related Expenses in SGA increase of 19% to EUR148.5M (expense), Impairment - Fixed Assets increase from EUR200K (income) to EUR16.4M (expense).
Odvětvová klasifikace
TRBC2012Healthcare Facilities & Services (NEC)
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSMedical Laboratories
NAICSGeneral Medical and Surgical Hospitals
NAICS2007Medical Laboratories
NAICS2007General Medical and Surgical Hospitals
NAICS1997Medical Laboratories
NAICS1997General Medical and Surgical Hospitals
SICMedical Laboratories
SICGeneral Med'L/surgical Hospitals



  • Poslední aktualizace: 06.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorFredrik Ragmark62
Chief Financial OfficerAnand Patel-01.10.202401.10.2024
Chief People OfficerKamila Skorupinska5201.04.202401.04.2024
Chief Information OfficerJaroslaw Urbanczyk5601.01.2019
Chief Marketing OfficerAndrew Vallance-Owen73
General Legal CounselJenny Brandt50
Chief Operating Officer, Healthcare ServicesJohn Stubbington57
Chief Operating Officer, Diagnostic ServicesStaffan Ternstroem5901.01.2021